Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis

被引:0
|
作者
Antonio Giovanni Solimando
Nicola Susca
Antonella Argentiero
Oronzo Brunetti
Patrizia Leone
Valli De Re
Rossella Fasano
Markus Krebs
Elisabetta Petracci
Irene Azzali
Oriana Nanni
Nicola Silvestris
Angelo Vacca
Vito Racanelli
机构
[1] Aldo Moro University of Bari,Guido Baccelli Unit of Internal Medicine, Department of Biomedical Sciences and Human Oncology, School of Medicine
[2] IRCCS Istituto Tumori Giovanni Paolo II of Bari,Bio
[3] Centro Di Riferimento Oncologico Di Aviano (CRO) IRCCS,Proteomics Facility, Department of Translational Research
[4] Aldo Moro University of Bari,Department of Biomedical Sciences and Human Oncology, School of Medicine
[5] University Hospital Würzburg,Comprehensive Cancer Center Mainfranken
[6] Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori (IRST) IRCCS,Unit of Biostatistics and Clinical Trials
来源
关键词
Hepatocellular carcinoma; Second-line treatment; Network meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:65 / 74
页数:9
相关论文
共 50 条
  • [21] Second-line systemic treatment for metastatic colorectal cancer: A systematic review and Bayesian network meta-analysis based on RCT
    Sun, Chengyu
    Fan, Enguo
    Huang, Luqiao
    Zhang, Zhengguo
    PLOS ONE, 2024, 19 (12):
  • [22] Systematic review and meta-analysis of recommended second-line therapies for advanced gastric cancer (GC)
    Liepa, A.
    Mitchell, S.
    Batson, S.
    Jen, M. H.
    Davie, A.
    Taipale, K.
    Hess, L.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S437 - S437
  • [23] The efficacy and safety of PARP inhibitors in mCRPC with HRR mutation in second-line treatment: a systematic review and bayesian network meta-analysis
    Zhu, Qiyu
    Chen, Junru
    Liu, Haoyang
    Zhao, Jinge
    Xu, Chenhao
    Sun, Guangxi
    Zeng, Hao
    BMC CANCER, 2024, 24 (01)
  • [24] A systematic review and meta-analysis of second-line therapies for treatment of mesothelioma
    Petrelli, Fausto
    Ardito, Raffaele
    Conti, Barbara
    Coinu, Andrea
    Cabiddu, Mary
    Ghilardi, Mara
    Borgonovo, Karen
    Barni, Sandro
    Ghidini, Antonio
    RESPIRATORY MEDICINE, 2018, 141 : 72 - 80
  • [25] Efficacy of Different Treatments for Patients with Advanced Hepatocellular Carcinoma: A System Review and Network Meta-Analysis
    Ling, Yunyan
    Jin, Meng
    Zhu, Meiyan
    Wang, Yan
    Chen, Yong
    Peng, Zhenwei
    INTERNATIONAL JOURNAL OF SURGERY-ONCOLOGY, 2022, 7 (01): : 58 - 67
  • [26] Second-Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta-Analysis
    Giannini, Edoardo G.
    Pasta, Andrea
    Calabrese, Francesco
    Labanca, Sara
    Marenco, Simona
    Pieri, Giulia
    Torres, Maria Corina Plaz
    Strazzabosco, Mario
    LIVER INTERNATIONAL, 2025, 45 (01)
  • [27] Primary treatments for solitary hepatocellular carcinoma ≤ 3 cm: A systematic review and network meta-analysis
    Kim, Sang-Hoon
    Kim, Ki-Hun
    Na, Byeong-Gon
    Kim, Sung Min
    Oh, Rak-Kyun
    ANNALS OF HEPATO-BILIARY-PANCREATIC SURGERY, 2024, 28 (04) : 397 - 411
  • [28] Bayesian network meta-analysis (NMA) comparison of second-line cytotoxic chemotherapies in advanced or metastatic gastric cancer
    Yamaguchi, Norihiro
    Fujii, Takeo
    Satta, Toshihisa
    Ajani, Jaffer A.
    Kozuch, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] Comparison of Efficacy and Safety of Third-Line Treatments for Advanced Gastric Cancer: A Systematic Review With Bayesian Network Meta-Analysis
    Huang, Miao
    Li, Jisheng
    Yu, Xuejun
    Xu, Qian
    Zhang, Xue
    Dai, Xin
    Li, Song
    Sheng, Lei
    Huang, Kai
    Liu, Lian
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [30] Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysis
    Park, Sejung
    Nam, Chung Mo
    Kim, Seul-Gi
    Mun, Ji Eun
    Rha, Sun Young
    Chung, Hyun Cheol
    EUROPEAN JOURNAL OF CANCER, 2021, 144 : 49 - 60